Hypoglycemic Agents: all 3,927 studies that test it
Page 36 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese SubjectsCompletedNCT00444561Phase 2
- A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy SubjectsCompletedNCT00443170Phase 1
- Effects of Rosiglitazone on Bone in Postmenopausal Diabetic WomenCompletedNCT00440375Phase 4
- SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)CompletedNCT00438568Phase 2
- Medication in Early Diabetes (MED) StudyWithdrawnNCT00437970Phase 4
- The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic PatientsCompletedNCT00437918Phase 4
- Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)CompletedNCT00437554Phase 3
- A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes MellitusTerminatedNCT00437164Phase 2
- Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 DiabetesCompletedNCT00437112Phase 3
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 DiabetesCompletedNCT00434850Phase 2
- Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus PioglitazoneCompletedNCT00433069Phase 2
- Detoxification and Treatment of Subjects With Medication Overuse HeadacheStatus unknownNCT00432549Phase 4
- Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOSCompletedNCT00428311Phase 4
- Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00427154Phase 3
- Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder InhalerStatus unknownNCT00426920Phase 1
- Effect of Januvia on Beta Cell Function in Patients With Diabetes MellitusCompletedNCT00425490Phase 3
- Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.CompletedNCT00424437Phase 3
- Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 DiabetesCompletedNCT00424333Phase 3
- Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.CompletedNCT00422955Phase 3
- Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese VolunteersCompletedNCT00419887Phase 1
- Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 DiabetesCompletedNCT00419718Phase 1
- Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy VolunteersCompletedNCT00414947Phase 1
- Metformin for the Treatment of Diabetes in PregnancyStatus unknownNCT00414245Phase 3
- The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory WomenCompletedNCT00413179Phase 3
- Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCICompletedNCT00412126Not applicable
- Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human InsulinCompletedNCT00410033Not applicable
- Effect of Rosiglitazone on ADMA in Critical IllnessStatus unknownNCT00409097Phase 3
- Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome ObesityStatus unknownNCT00408850Phase 3
- Lantus Versus Levemir Treat-To-TargetCompletedNCT00405418Phase 4
- The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.CompletedNCT00405015Phase 2
- Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or RosiglitazoneCompletedNCT00402909Phase 4
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsCompletedNCT00402077Phase 2
- "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DMCompletedNCT00402012Phase 4
- The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) StudyCompletedNCT00400231Phase 2
- A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes MellitusCompletedNCT00399724Phase 4
- Insulin Glulisine, Diabetes Mellitus Type 1CompletedNCT00397553Phase 3
- Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 DiabetesStatus unknownNCT00396851Not applicable
- The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.SuspendedNCT00396734Not applicable
- Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.Status unknownNCT00396513Not applicable
- Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin AloneCompletedNCT00396357Phase 3
- Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin AloneCompletedNCT00396227Phase 3
- Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With MetforminCompletedNCT00396071Phase 3
- Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With PsoriasisCompletedNCT00395941Phase 2
- An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.CompletedNCT00391261Phase 4
- Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)CompletedNCT00390728Phase 4
- Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 DiabetesCompletedNCT00390520Phase 3
- Effect of Metformin on Lactate MetabolismCompletedNCT00390273Phase 1/2
- Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 DiabetesCompletedNCT00389415Phase 3
- A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.CompletedNCT00388986Phase 1
- Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or MetforminCompletedNCT00384215Phase 4
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00383877Phase 3
- Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 DiabetesCompletedNCT00383578Phase 3
- Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 DiabetesCompletedNCT00382096Phase 3
- Double-Blind Study of Miglitol in Japanese With type2 DiabetesCompletedNCT00380822Phase 3
- Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 DiabetesCompletedNCT00380445Phase 3
- A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.CompletedNCT00380380Phase 3
- The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid ArthritisCompletedNCT00379600Phase 2
- "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous FatCompletedNCT00377975Phase 2
- PIoglitazone for PrEvention of Restenosis in Diabetic PatientsStatus unknownNCT00376870Phase 3
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3
- Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 DiabetesCompletedNCT00376038Phase 1
- Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 DiabetesCompletedNCT00373178Phase 4
- Rosiglitazone and Insulin in T1DM AdolescentsCompletedNCT00372086Phase 4
- Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin ResistanceStatus unknownNCT00370617Phase 4
- Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.CompletedNCT00370565Phase 3
- 11ß-HSD1 and Metabolic SyndromeCompletedNCT00370305Phase 2
- Topiramate on Gambling-Related BehavioursWithdrawnNCT00370188Phase 2
- Rosiglitazone Maleate in Treating Patients With Oral LeukoplakiaCompletedNCT00369174Phase 2
- Dose-Exposure-Response in Type 1 Diabetes MellitusCompletedNCT00368394Phase 1
- To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 DiabetesCompletedNCT00368134Phase 3
- Metabolic Effects of Thiazolidinediones in Chronic Kidney DiseaseTerminatedNCT00368017Phase 2
- A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and LantusCompletedNCT00367445Phase 4
- Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 DiabetesCompletedNCT00365170Phase 4
- Pioglitazone and Losartan Provides Additional RenoprotectionCompletedNCT00364988Not applicable
- Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic SyndromeCompletedNCT00364221Phase 4
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363948Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363844Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363519Phase 3
- Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyTerminatedNCT00362765Phase 2/3
- Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate RosiglitazoneCompletedNCT00362726Phase 1
- Prevention of Severe Hypoglycemia in Type 1 DiabetesCompletedNCT00360984Phase 4
- AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 DiabetesCompletedNCT00359112Phase 3
- A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human InsulinCompletedNCT00358553Phase 1
- Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination TherapyCompletedNCT00358124Phase 4
- Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 DiabetesCompletedNCT00355849Phase 3
- Insulin Analogue With Continuous Glucose Monitoring System (CGMS) MeasurementCompletedNCT00354939Phase 4
- Bioavailability of Insulin Administered in DuodenumCompletedNCT00353990Phase 1/2
- Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusCompletedNCT00353691Phase 3
- Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic AdultsCompletedNCT00352287Phase 4
- A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 DiabetesCompletedNCT00351832Phase 3
- A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 DiabetesCompletedNCT00351585Phase 3
- A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 DiabetesCompletedNCT00351546Phase 3
- A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 DiabetesCompletedNCT00351507Phase 3
- A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.CompletedNCT00349635Phase 2
- A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus PatientsCompletedNCT00349427Phase 3
- Lantus in PrediabetesCompletedNCT00348972Phase 1
- Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00348712Phase 3
- Insulin Glargine in Type 2 Diabetic PatientsCompletedNCT00347100Phase 4
- Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00343980Phase 3
- Lunch Time Insulin Injection by School Nurse for Poorly Controlled DiabetesCompletedNCT00340613Phase 4